• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    TIAN RUIXIANG Holdings Ltd Reports Financial Results for Fiscal Year Ended October 31, 2023

    7/17/24 5:42:09 PM ET
    $TIRX
    Specialty Insurers
    Finance
    Get the next $TIRX alert in real time by email

    BEIJING, July 17, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the fiscal year ended October 31, 2023.

    Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "For the year ended October 31, 2023, the Company generated revenue of about $1.2 million, representing an 8.0% decrease compared to the prior year's revenue. This decline was primarily attributable to the lower commissions from several insurance products and loss of certain insurance company partners amid an increasingly competitive market and challenging macroeconomic environment in China."

    "However, we achieved a significant increase of approximately $612,000 in the commissions from our liability insurance products, driven by our efforts to expand our liability insurance business."

    "Despite the revenue decline, we were able to reduce the net loss by 47.6% to $2.5 million, down from $4.7 million in the prior year. Overall, while we faced headwinds in certain insurance products, we were able to drive substantial growth in the liability insurance commissions, which is a positive indicator for the Company's strategic focus. Additionally, the reduction in the net loss demonstrates improved financial performance and operational efficiency compared to the prior year."

    Selected Fiscal Year 2023 Financial Metrics

      Years Ended October 31,

     Changes in 
    ($ in millions, except per share data, differences due to rounding.) 2023

     2022

     Percentage 
    Revenues $1.2 $1.4 (8.0)%
    Total operating expenses  4.3  6.4 (33.6)%
    Loss from operations   (3.0)   (5.1)  (40.5)%
    Net loss   (2.5)   (4.7)  (47.6)%
    Loss per share   (3.87)   (9.03)  (55.4)%


    • Revenue decreased by 8.0% to $1.2 million for the year ended October 31, 2023, compared with $1.4 million for the same period in 2022.
    • Total operating expenses were $4.3 million for the year ended October 31, 2023, decreased from $6.4 million for the same period in 2022.
    • Loss from operations narrowed by 40.5% to $3.0 million for the year ended October 31, 2023, from $5.1 million for the same period in 2022.
    • Net loss also decreased by 47.6% to $2.5 million for the year ended October 31, 2023, from $4.7 million for the same period in 2022.

    About TIAN RUIXIANG Holdings Ltd

    TIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker operating in China through its China-based variable interest entity. It distributes a wide range of insurance products, which are categorized into two major groups: (1) property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and (2) other types of insurance, such as health insurance, life insurance, and other miscellaneous insurance. For more information, visit the company's website at http://ir.tianrx.com/.

    Forward-Looking Statements

    Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review risk factors that may affect its future results in the Company's registration statement and in its other filings with the U.S. Securities and Exchange Commission.

    For investor and media enquiries, please contact:

    TIAN RUIXIANG Holdings Ltd

    Investor Relations Department

    Email: [email protected]

    Wealth Financial Services LLC

    Connie Kang

    Partner

    Email: [email protected]

    Tel: +86 1381 185 7742 (CN)



    TIAN RUIXIANG HOLDINGS LTD AND SUBSIDIARIES



    CONSOLIDATED BALANCE SHEETS



    (IN U.S. DOLLARS)
     
           
      As of October 31,
      2023  2022 
    ASSETS      
           
    CURRENT ASSETS:      
    Cash $2,383  $2,508 
    Restricted cash  692,692   692,734 
    Short-term investments  26,797,081   26,179,662 
    Accounts receivable  18,960   51,202 
    Note receivable  —   7,500,000 
    Interest receivable  —   262,192 
    Due from related party  —   1,369 
    Other current assets  107,508   168,957 
           
    Total Current Assets  27,618,624   34,858,624 
           
    NON-CURRENT ASSETS:      
    Note receivable  7,800,000   — 
    Property and equipment, net  6,280   8,688 
    Right-of-use assets, operating leases, net  54,870   143,438 
    Other non-current assets  —   20,078 
           
    Total Non-current Assets  7,861,150   172,204 
           
    Total Assets $35,479,774  $35,030,828 
           
    LIABILITIES AND EQUITY      
           
    CURRENT LIABILITIES:      
    Taxes payable $623,825  $466,878 
    Salary payable  726,330   424,987 
    Accrued liabilities and other payables  481,801   384,893 
    Due to related parties  1,173,510   126,530 
    Operating lease liabilities  57,402   90,800 
           
    Total Current Liabilities  3,062,868   1,494,088 
           
    NON-CURRENT LIABILITIES:      
    Operating lease liabilities - noncurrent portion  —   54,718 
           
    Total Non-current Liabilities  —   54,718 
           
    Total Liabilities  3,062,868   1,548,806 
           
           
    EQUITY:      
    TIAN RUIXIANG Holdings Ltd Shareholders' Equity:      
    Ordinary shares: $0.025 par value; 40,000,000 shares authorized;      
    Class A ordinary shares: $0.025 par value; 36,000,000 shares authorized; 674,949 shares issued and outstanding at October 31, 2023; 507,440 shares issued and 505,440 shares outstanding at October 31, 2022  16,874   12,636 
    Class B ordinary shares: $0.025 par value; 4,000,000 shares authorized; 50,000 shares issued and outstanding at October 31, 2023 and 2022  1,250   1,250 
    Additional paid-in capital  44,108,774   42,663,012 
    Less: ordinary stock held in treasury, at cost; 0 share at October 31, 2023 and 2,000 shares at October 31, 2022  —   — 
    Accumulated deficit  (8,303,691)  (5,800,817)
    Statutory reserve  275,150   226,253 
    Accumulated other comprehensive loss  (3,681,845)  (3,620,712)
    Total TIAN RUIXIANG Holdings Ltd shareholders' equity  32,416,512   33,481,622 
    Non-controlling interest  394   400 
           
    Total Equity  32,416,906   33,482,022 
           
    Total Liabilities and Equity $35,479,774  $35,030,828 
             



    TIAN RUIXIANG HOLDINGS LTD AND SUBSIDIARIES



    CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS



    (IN U.S. DOLLARS)
     
      For the Years Ended October 31,
      2023  2022  2021 
              
    REVENUES         
    Commissions $1,244,247  $1,324,655  $2,675,611 
    Risk management services  —   27,254   115,006 
              
    Total Revenues  1,244,247   1,351,909   2,790,617 
              
    OPERATING EXPENSES         
    Selling and marketing  2,438,248   1,764,909   2,517,497 
    General and administrative - professional fees  1,220,367   1,185,930   1,011,053 
    General and administrative - compensation and related benefits  460,791   2,691,751   948,900 
    General and administrative - other  141,167   654,587   566,971 
    Impairment loss  —   123,646   — 
              
    Total Operating Expenses  4,260,573   6,420,823   5,044,421 
              
    LOSS FROM OPERATIONS  (3,016,326)  (5,068,914)  (2,253,804)
              
    OTHER INCOME (EXPENSE)         
    Interest income  731,961   434,406   315,070 
    Other (expense) income  (8,278)  (26,042)  18,686 
              
    Total Other Income, net  723,683   408,364   333,756 
              
    LOSS BEFORE INCOME TAXES  (2,292,643)  (4,660,550)  (1,920,048)
              
    INCOME TAXES  161,339   23,639   24,529 
              
    NET LOSS $(2,453,982) $(4,684,189) $(1,944,577)
              
    LESS: NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST  (5)  (32)  (28)
              
    NET LOSS ATTRIBUTABLE TO TIAN RUIXIANG HOLDINGS LTD ORDINARY SHAREHOLDERS $(2,453,977) $(4,684,157) $(1,944,549)
              
    NET LOSS PER ORDINARY SHARE ATTRIBUTABLE TO TIAN RUIXIANG HOLDINGS LTD ORDINARY SHAREHOLDERS:         
    Basic and diluted $(3.87) $(9.03) $(5.65)
              
    WEIGHTED AVERAGE ORDINARY SHARES OUTSTANDING:         
    Basic and diluted  633,336   518,655   344,425 
              
    COMPREHENSIVE LOSS:         
    NET LOSS $(2,453,982) $(4,684,189) $(1,944,577)
    OTHER COMPREHENSIVE (LOSS) INCOME         
    Unrealized foreign currency translation (loss) gain  (61,134)  (3,717,478)  214,123 
    COMPREHENSIVE LOSS  (2,515,116)  (8,401,667)  (1,730,454)
    LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST  (6)  (89)  (6)
    COMPREHENSIVE LOSS ATTRIBUTABLE TO TIAN RUIXIANG HOLDINGS LTD ORDINARY SHAREHOLDERS $(2,515,110) $(8,401,578) $(1,730,448)
                 



    TIAN RUIXIANG HOLDINGS LTD AND SUBSIDIARIES



    CONSOLIDATED STATEMENTS OF CASH FLOWS



    (IN U.S. DOLLARS)
     
      For the Years Ended October 31,
      2023  2022  2021 
              
    CASH FLOWS FROM OPERATING ACTIVITIES:         
    Net loss $(2,453,982) $(4,684,189) $(1,944,577)
    Adjustments to reconcile net loss to net cash provided by (used in) operating activities:         
    Depreciation expense and amortization of intangible assets  1,631   22,853   27,447 
    Amortization of right-of-use assets  78,126   185,421   227,661 
    Impairment loss  —   123,646   696 
    Stock-based compensation and service expense  1,450,000   2,888,787   — 
    Bad debt provision  7,338   —   — 
    Loss on disposal of property and equipment  848   —   — 
    Changes in operating assets and liabilities:         
    Accounts receivable  25,983   254,109   969,374 
    Security deposit  6,726   37,853   (43,750)
    Interest receivable  262,192   (149,178)  (113,014)
    Due from related party  1,417   (1,511)  — 
    Other assets  91,348   495,668   (74,120)
    Taxes payable  163,500   36,553   (78,932)
    Salary payable  347,567   349,436   — 
    Accrued liabilities and other payables  99,649   304,576   (123,052)
    Due to related parties  992,277   126,228   12,025 
    Operating lease liabilities - related party  —   —   (29,355)
    Operating lease liabilities  (80,316)  (189,012)  (194,341)
              
    NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES  994,304   (198,760)  (1,363,938)
              
    CASH FLOWS FROM INVESTING ACTIVITIES:         
    Purchase of property and equipment  —   (2,346)  (3,411)
    Investment in note receivable  (7,800,000)  —   (7,500,000)
    Proceeds from note receivable  7,500,000   —   — 
    Purchase of short-term investments  (27,779,231)  (29,011,783)  - 
    Proceeds from sale of short-term investments  27,086,514   116,663   - 
              
    NET CASH USED IN INVESTING ACTIVITIES  (992,717)  (28,897,466)  (7,503,411)
              
    CASH FLOWS FROM FINANCING ACTIVITIES         
    Proceeds from note payable  —   —   75,581 
    Repayment of note payable  —   —   (75,581)
    Proceeds from related parties' borrowings  9,535   225,171   1,893,932 
    Repayments of related parties' borrowings  (9,818)  (225,171)  (2,272,145)
    Proceeds from initial public offering  —   —   12,300,000 
    Disbursements for initial public offering costs  —   —   (1,489,388)
    Proceeds from the June 2021 public offering  —   —   24,562,500 
    Disbursements for the June 2021 public offering costs  —   —   (2,352,418)
              
    NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES  (283)  —   32,642,481 
              
    EFFECT OF EXCHANGE RATE ON CASH AND RESTRICTED CASH  (1,471)  (1,052,173)  145,014 
              
    NET (DECREASE) INCREASE IN CASH AND RESTRICTED CASH  (167)  (30,148,399)  23,920,146 
              
    CASH AND RESTRICTED CASH - beginning of year  695,242   30,843,641   6,923,495 
              
    CASH AND RESTRICTED CASH - end of year $695,075  $695,242  $30,843,641 
              
    SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:         
    Cash paid for:         
    Interest $—  $22  $725 
    Income taxes $807  $—  $2,251 
              
    NON-CASH INVESTING AND FINANCING ACTIVITIES         
    Reissuance of treasury stock $25,000  $—  $— 
    Payments made by related parties on the Company's behalf $1,068,700  $—  $119,886 
              
    RECONCILIATION OF CASH AND RESTRICTED CASH         
    Cash at beginning of year $2,508  $30,024,372  $6,137,689 
    Restricted cash at beginning of year  692,734   819,269   785,806 
    Total cash and restricted cash at beginning of year $695,242  $30,843,641  $6,923,495 
              
    Cash at end of year $2,383  $2,508  $30,024,372 
    Restricted cash at end of year  692,692   692,734   819,269 
    Total cash and restricted cash at end of year $695,075  $695,242  $30,843,641 
                 


    Primary Logo

    Get the next $TIRX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TIRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TIRX
    SEC Filings

    See more
    • SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

      6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

      5/30/25 6:04:39 AM ET
      $TIRX
      Specialty Insurers
      Finance
    • SEC Form 20-F filed by TIAN RUIXIANG Holdings Ltd

      20-F - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

      1/31/25 4:30:45 PM ET
      $TIRX
      Specialty Insurers
      Finance
    • SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

      6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

      1/29/25 8:45:58 AM ET
      $TIRX
      Specialty Insurers
      Finance

    $TIRX
    Financials

    Live finance-specific insights

    See more
    • TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Half Year Ended April 30, 2024

      BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the half year ended April 30, 2024. Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "The Company reported a net loss of approximately $2.6 million for the six months ended April 30, 2024, primarily due to a significant decline in revenue caused by the loss of a few key insurance company partners. However, we are encouraged by the increase in the commissions from liability insurance of approximately $24,000 compared to t

      8/16/24 4:15:15 PM ET
      $TIRX
      Specialty Insurers
      Finance
    • TIAN RUIXIANG Holdings Ltd Announces 2021 Performance Incentive Plan

      BEIJING, Dec. 8, 2021 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), a China-based insurance broker, announced today that the Company adopted a performance incentive plan (the "2021 Plan") to motivate and reward eligible employees based on their performance.  The Company has also filed a registration statement on Form S-8 (the "Registration Statement") to register 5,000,000 Class A ordinary shares, par value of US$0.001 per share (the "Class A Ordinary Shares"), of the Company, issuable pursuant to the the 2021 Plan. In accordance with Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers an indete

      12/8/21 9:00:00 AM ET
      $TIRX
      Specialty Insurers
      Finance

    $TIRX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

      BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

      5/30/25 6:10:00 AM ET
      $TIRX
      Specialty Insurers
      Finance
    • TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Half Year Ended April 30, 2024

      BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the half year ended April 30, 2024. Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "The Company reported a net loss of approximately $2.6 million for the six months ended April 30, 2024, primarily due to a significant decline in revenue caused by the loss of a few key insurance company partners. However, we are encouraged by the increase in the commissions from liability insurance of approximately $24,000 compared to t

      8/16/24 4:15:15 PM ET
      $TIRX
      Specialty Insurers
      Finance
    • TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq's Periodic Filing Requirement

      BEIJING, July 23, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced that the Company received a written notification from the Nasdaq Stock Market LLC ("Nasdaq") on July 18, 2024, informing the Company that it has regained compliance with Nasdaq's periodic filing requirement set forth under Listing Rule 5250(c)(1), because the Company had filed its annual report on Form 20-F for the period ended October 31, 2023 on July 17, 2024. About TIAN RUIXIANG Holdings Ltd TIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker

      7/23/24 8:30:00 AM ET
      $TIRX
      Specialty Insurers
      Finance

    $TIRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by TIAN RUIXIANG Holdings Ltd

      SC 13G/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

      11/13/24 11:16:48 AM ET
      $TIRX
      Specialty Insurers
      Finance
    • SEC Form SC 13D filed by TIAN RUIXIANG Holdings Ltd

      SC 13D - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

      6/10/24 6:15:45 AM ET
      $TIRX
      Specialty Insurers
      Finance
    • SEC Form SC 13D/A filed by TIAN RUIXIANG Holdings Ltd (Amendment)

      SC 13D/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

      6/10/24 6:08:20 AM ET
      $TIRX
      Specialty Insurers
      Finance

    $TIRX
    Leadership Updates

    Live Leadership Updates

    See more
    • TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

      BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

      5/30/25 6:10:00 AM ET
      $TIRX
      Specialty Insurers
      Finance